Potential markers of preeclampsia--a review

Simon Grill1, Corinne Rusterholz, Rosanna Zanetti-Dällenbach

  • 1Laboratory for Prenatal Medicine and Gynecologic Oncology, Department of Biomedicine, University Hospital of Basel, Basel, Switzerland. sgrill@uhbs.ch

Insights

Early identification of preeclampsia risk is crucial for maternal and fetal health. Research is exploring new biochemical markers for accurate prediction and timely intervention in preeclampsia.

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Biochemistry

Background:

  • Preeclampsia is a major global cause of maternal and neonatal mortality.
  • Early risk identification is a critical goal in obstetrics.
  • Improved diagnostic tools are needed for timely intervention and research.

Purpose of the Study:

  • To review the current understanding of preeclampsia biology.
  • To identify and discuss potential biochemical markers for preeclampsia prediction and diagnosis.
  • To highlight the need for sensitive and specific markers in clinical practice.

Main Methods:

  • Literature review of preeclampsia biology.
  • Analysis of existing and emerging biochemical markers.
  • Discussion of the potential for combined marker analysis.

Main Results:

  • Preeclampsia poses significant risks to mothers and newborns.
  • Several biochemical markers show promise for predicting preeclampsia.
  • Combinatorial analysis of markers may enhance diagnostic accuracy.

Conclusions:

  • Accurate prediction and diagnosis of preeclampsia are essential.
  • Biochemical markers are key to advancing preeclampsia monitoring.
  • Future research will focus on validated marker panels for clinical use.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...